Airsculpt Technologies, Inc. (AIRS) Stock Forecast Oct. 13, 2026
Analysis updated on Oct. 13, 2026 (UTC) · Total · absolute moveSwitch to Alpha · Nasdaq
Airsculpt Technologies, Inc. (AIRS) stock forecast summary
Our AI ranks Airsculpt Technologies, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Airsculpt Technologies, Inc. is a small-cap company with a market capitalization of $117M. It ranks number 4 by market capitalization among the 5 Services-Offices & Clinics of Doctors of Medicine issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for AIRS is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +4.5%, buy ≥ +3.4%, sell < +2.1%, strong sell < +0.9% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, AIRS included.
Follow AIRS freeAIRS price chart and AI forecast
How AIRS ranks among 5379 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Airsculpt Technologies, Inc. (AIRS) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Offices & Clinics of Doctors of Medicine peers listed below that report each metric.
Valuation & Market
| Metric | AIRS | Rank |
|---|---|---|
| Market Cap | $117M | 4/5 |
| P/B Ratio | 1.11x | – |
| EPS | $-0.23 | – |
| Book Value/Share | $1.45 | – |
| Revenue/Share | $2.09 | – |
| FCF/Share | $0.08 | – |
Profitability & Margins
| Metric | AIRS | Rank |
|---|---|---|
| ROE | -0.9% | 2/6 |
| ROA | -0.5% | 2/8 |
| ROIC | -8.0% | 4/8 |
| Gross Margin | 59.5% | 6/6 |
| Operating Margin | -8.4% | 6/8 |
| Net Margin | -0.6% | 3/8 |
| EBT Margin | -11.9% | 5/8 |
| Tax Rate | 33.8% | – |
Financial Health
| Metric | AIRS | Rank |
|---|---|---|
| Current Ratio | 0.79x | 7/8 |
| D/E Ratio | 0.84x | 5/6 |
| Financial Leverage | 1.84x | 5/6 |
| Interest Coverage | -0.0x | 3/8 |
| Working Capital | -$7M | 6/8 |
Cash Flow
| Metric | AIRS | Rank |
|---|---|---|
| Operating Cash Flow | $7M | 4/8 |
| Free Cash Flow | $6M | 4/6 |
| Capital Spending | -$570K | 1/6 |
| OCF Growth YoY | -37.0% | 4/5 |
| FCF Growth YoY | 142.5% | – |
| FCF/Sales | 4.0% | 3/6 |
| CapEx/Sales | 0.4% | 5/6 |
Operational Efficiency
| Metric | AIRS | Rank |
|---|---|---|
| Asset Turnover | 0.78x | 5/7 |
| Fixed Assets Turnover | 6.2x | 6/6 |
| Payables Period | 44 days | 4/5 |
Income Statement
| Metric | AIRS | Rank |
|---|---|---|
| Total Revenue | $150M | 6/7 |
| Operating Income | -$12M | 4/8 |
| Net Income | $0.00M | 2/8 |
| SG&A Expense | $84M | 4/7 |
| Cost of Goods Sold | $61M | 3/6 |
Dividend & Shareholder Information
| Metric | AIRS | Rank |
|---|---|---|
| Shares Outstanding | 72M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $28M | 14.2% of assets |
| Cash & Short-term Investments | $19M | 9.7% of assets |
| Total Liabilities | $88M | 45.8% of assets |
| Short-term Debt | $28M | 14.3% of assets |
AIRS quarterly financials and insider trading
Airsculpt Technologies, Inc. (AIRS) industry peers
Companies classified under the same SEC industry code as Airsculpt Technologies, Inc. (Services-Offices & Clinics of Doctors of Medicine): 8 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| AIRS Airsculpt Technologies, Inc. | ▲ | $117M |
| TDOC Teladoc Health, Inc. | ▲ | $1.09B |
| SBC Sbc Medical Group Holdings Inc | ▼ | $547M |
| LFMD Lifemd, Inc. | ▲ | $119M |
| HLYK Healthlynked Corp | ▶ | $7M |
| CDIX Cardiff Lexington Corp | ▼ | N/A |
| HIMS Hims & Hers Health, Inc. | ▲ | N/A |
| STLN Starling Oncology, Inc. | ▲ | N/A |
Where AIRS sits on the market map
Airsculpt Technologies, Inc. (AIRS) stock news
Loading...
Airsculpt Technologies, Inc. (AIRS) stock forecast FAQ
What is the Airsculpt Technologies, Inc. (AIRS) stock forecast?
Our AI ranks Airsculpt Technologies, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Airsculpt Technologies, Inc. stock predictions?
A per-ticker accuracy statistic for AIRS is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Airsculpt Technologies, Inc. forecasts updated?
Airsculpt Technologies, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Which companies are Airsculpt Technologies, Inc.'s industry peers?
8 issuers in our coverage, AIRS included, share the SEC industry code Services-Offices & Clinics of Doctors of Medicine. The largest are: Teladoc Health, Inc. (TDOC), Sbc Medical Group Holdings Inc (SBC), Lifemd, Inc. (LFMD), Healthlynked Corp (HLYK), Cardiff Lexington Corp (CDIX), Hims & Hers Health, Inc. (HIMS).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.